Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5564
Source ID: NCT01779375
Associated Drug: Metformin
Title: RISE Pediatric Medication Study
Acronym: RISE Peds
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01779375/results
Conditions: Prediabetes|Type 2 Diabetes
Interventions: DRUG: Metformin|DRUG: Glargine
Outcome Measures: Primary: ß-cell Response Measured by Hyperglycemic Clamp, Clamp measures of ß-cell response, co-primary outcomes, 3-months after medication washout (Month 15)|M/I, Clamp measure of insulin sensitivity, 3-months after a medication washout | Secondary: ACPRg, First phase response, 3-months after a medication washout|ß-cell Function Measured by Hyperglycemic Clamp Techniques at M12, Participants had 12-months of active therapy. Secondary results at the end of active intervention., End of active intervention (Month 12).|Clamp Measure of Insulin Sensitivity, Participants had 12-months of active therapy. Secondary results at the end of active intervention., End of active intervention (Month 12) | Other: OGTT Measures of ß-cell Function and Glucose Tolerance, Measures derived the OGTT at the end of the 12 month active intervention period, and following a 3-month and 9-month washout., After 12 months of active treatment, and 3 and 9 months of washout
Sponsor/Collaborators: Sponsor: RISE Study Group | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Gender: ALL
Age: CHILD, ADULT
Phases: PHASE3
Enrollment: 91
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2013-06-16
Completion Date: 2018-04
Results First Posted: 2018-10-09
Last Update Posted: 2023-04-14
Locations: Childrens Hospital Colorado, Denver, Colorado, 80045, United States|Yale School of Medicine Pediatric Obesity and Type 2 Diabetes Clinic, New Haven, Connecticut, 06511, United States|Indiana University, Indianapolis, Indiana, 46202, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States
URL: https://clinicaltrials.gov/show/NCT01779375